r/stockpicksdaily

Most people who followed $CYDY remember March 30, 2021. The FDA publicly stated that CytoDyn's claims about leronlimab were "misleading and not supported by the data", no benefit was shown in COVID-19 treatment trials. The stock dropped 25%+ that day.

What happened afterward was a class action lawsuit covering investors who held $CYDY between March 27, 2020 and March 30, 2022.

A $500,000 settlement has been reached and terms are now submitted to the court for approval.

Who qualifies?

Anyone who held $CYDY during the class period and suffered losses from the alleged misrepresentations about leronlimab's effectiveness for HIV and COVID-19.

Can I still apply?

Yes, you can submit your application now and it will be processed once claims filing officially opens after court approval.

If you were damaged by this don't forget to check your eligibility. GL!

Wendy's stock was at $6 (52-week low), a Reddit post went viral, stock jumped 25%+ in one day, trading got halted, Roaring Kitty tweeted about it, 24% short interest makes it a squeeze candidate, but the actual company fundamentals are rough. Do your own DD.

WHAT HAPPENED

On June 24, u/ElegantCombination43 posted "We need to save Wendy's before it's too late" on r/WallStreetBets. It blew up with 21,000+ upvotes. Within hours, retail traders flooded in.

Price Action:

• June 23: $6.26 close (hit 52-week low of $6.07 that day)
• June 24: Opened $7.81, hit $8.89 high, closed $7.86 (+25.66%)
• Volume: 210M shares (normal is ~8M, that's 26x)
• NYSE halted trading for volatility
• June 25: Hit $9.07 then crashed to $7.57 (-3.7%). Day 2 failed.

WHY WENDY'S? THE SETUP WAS PERFECT

1. Beaten-down price: Down ~70% from ATH of $22.78 (2021)
2. High short interest: 23-24% of float shorted (textbook squeeze setup)
3. Retail attention: Stocktwits saw 312% surge, Vanda flagged 7x abnormal buying
4. Brand nostalgia: "Save Wendy's" narrative hit different

ROARING KITTY ENTERED THE CHAT

Keith Gill posted on X June 24: "At market open, we ride." He followed with: "For the bagholders. For the believers. For every man who ever stared at a 4-for-4 and saw freedom. Wendy's, open the gates." Added fuel to the fire.

Not financial advice. Meme stocks are extremely volatile. Fundamentals are genuinely weak. Do your own research, set stop losses, never bet more than you can afford to lose.

This might be the most self-destructive acquisition announcement I have ever seen in the semiconductor space. Let me break it down.

WHAT HAPPENED

On June 26 after market close, ON Semiconductor (ON) announced it would acquire Synaptics (SYNA) in an all-stock deal valued at approximately $7 billion. It is the largest acquisition in ON's corporate history.

The next morning, June 27, ON stock cratered 23.7%, closing at $90.65. That single-day wipeout erased approximately $6.6 billion in equity value from ON's market cap.

Let that sink in. The deal is worth $7 billion. The stock drop alone cost shareholders $6.6 billion. ON basically destroyed almost the entire value of the acquisition in its own stock price in ONE trading session.

THE DEAL DETAILS

• Structure: All-stock. Synaptics shareholders receive 1.35 ON shares for each SYNA share.
• Premium: ~19% over 10-day volume-weighted average prices.
• Synaptics ownership post-deal: ~12% of the combined company.
• New shares issued: Approximately 70 million ON shares against an existing base of 391.9 million. That is roughly 18% dilution.
• Projected synergies: $200 million in annual cost savings.
• Expected close: Mid-2027.
• Strategic rationale: ON calls it "Physical AI" (robotics, drones, autonomous vehicles). Synaptics brings edge AI compute, human-machine interface tech, and connectivity solutions. ON says the deal expands its total addressable market by $30 billion.

WHY THE MARKET HATED IT

1. The dilution math is brutal. An 18% share dilution in an all-stock deal means existing ON shareholders are giving up a massive chunk of ownership. When your stock drops 24% on top of that, the combined hit is devastating.

2. Strategic mismatch. ON Semiconductor's core business is automotive, industrial, and AI data center chips. Synaptics has approximately 60% exposure to consumer and wireless markets, which is a very different business. TD Cowen downgraded ON to Hold specifically because of this, calling the consumer exposure "far removed from ON's core automotive, industrial, and AI data center strengths."

3. The stock was already up 119% YTD. ON had been one of the best-performing semiconductor stocks of 2026, riding the AI data center boom. Announcing a massive dilutive deal right after a 119% rally is terrible timing. Investors had already priced in ON as a pure AI data center play, not a consumer electronics conglomerate.

4. No immediate earnings boost. ON guided Q2 EPS to $0.65-$0.77 (consensus $0.71), roughly in line. The deal is not expected to be accretive to earnings for 18 months. Investors want growth now, not promises.

5. The irony. Synaptics stock barely moved (up ~3-5% on the news). The market essentially said: "SYNA is fine, but ON just made a terrible deal." ON's stock fell so much that the implied value of Synaptics per ON share actually DECREASED from $160.30 to $137.50 before the market even opened.

ANALYST REACTIONS

TD Cowen (downgraded to Hold, PT $110 from $115): "The acquisition adds complexity to a model that depends on loading-driven earnings growth. Synaptics carries ~60% exposure to consumer and wireless markets, far from ON's core strengths."

Robert W. Baird (Hold, PT $100): Cited concerns about strategic fit and AI positioning.

Jefferies: Said the deal "makes strategic sense" for diversification but cautioned it "is not structured to deliver an immediate earnings boost."

This is not financial advice, Always do your own research.

Man, it’s been a wild ride, we’re witnessing an insane memory super cycle.

The Headline Numbers:

Revenue: $41.46 billion. One year ago this quarter it was $9.30 billion. That is +346% year-over-year.

Non-GAAP EPS: $25.11. One year ago it was $1.91. That is +1,215% year-over-year.

Gross margin: 84.9%. One year ago it was 39%. They literally doubled margins.

Beat consensus on revenue by ~$6 billion. Beat EPS consensus by ~$4.40.
Guides Q4 to $50B revenue and $31 EPS. Consensus was $43.2B and $25.31.

That Q4 guidance beat alone is almost $7 billion above what Wall Street expected. For a single quarter guidance raise, that is enormous.

The Quarterly Ramp This Year Has Been Vertical

Q1 (Dec 2025): $13.64B revenue, $4.78 EPS
Q2 (Mar 2026): $23.86B revenue, $12.20 EPS
Q3 (Jun 2026): $41.46B revenue, $25.11 EPS
Q4 (guided): ~$50B revenue, ~$31 EPS

Full year estimated around $129B in revenue. Last fiscal year was $37.4B. That is a 3.4x increase in one year for a company this size.

Wide moat, all-weather financial infrastructure. Seems like the time to buy.